RS

Rakib Saikia

Director Managing Director DIN 00004991
DIN 00004991 First appointment Mar 2006 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2006
Shareholding value Locked Premium profile

About Rakib Saikia

Rakib Saikia has 20 years in corporate governance. Holds Managing Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 00004991
Primary Designation Managing Director
First Appointment 03 Mar 2006
Oldest Company Age 20 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Sigmund Pharma Private Limited U72100AS2006PTC008084
Managing Director 03 Mar 2006 2006 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sigmund Pharma Private Limited
Premium access

Shareholding and investment profile for Rakib Saikia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakib Saikia

Rakib Saikia has 20 years in corporate governance. Holds Managing Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Rakib Saikia is associated with 0 companies as Managing Director.

Rakib Saikia has expertise in General Business.

Rakib Saikia has 20 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available